Accelerating projects in
Clinical Research and
Market Access in
Emerging Markets
A WORD FROM OUR CEO, SARA TYLOSKY:
“We bring our medical associates and alliances together for our client’s successful outcomes – all in a patient-centric way. Latin American is a region of 660 million people and it is a land of opportunity for clinical research and market access with an epidemiological profile resembling that of the Unites States – as well as diversity profiles when sought. Navigating the unique cultural and logistical challenges of Latin American and emerging markets is our specialty. Let’s brainstorm today.”
WHAT FARMACON CAN DO FOR YOU:
Farmacon Global’s strategic solutions accelerate clinical trials and market access in emerging markets – such as Latin America – through our on-the-ground medical associates and alliances, where every patient and every community counts… all to the benefit of our clients’ successful outcomes.
Latin America Solution For Disrupted Clinical Trials Due To The Conflict In Ukraine
A database of privately and publicly funded clinical studies conducted around the world from 220 countries shows that there are 5,934 registered clinical studies in the Russian Federation and over 2,400 in Ukraine, not to mention over 300 in Belarus.